DCLK1 and pancreatic neoplasm: Therefore, inhibition of glycolysis signalling, up‐regulation of ROS generation and/or silencing of DCLK1 may be effective approaches to eliminating CSCs, reversing the EMT phenotype and thus eradicating chemoresistant cancer cells to improve the prognosis of patients with pancreatic cancer.